Oral sensory and cephalic hormonal responses to fat and non-fat liquids in bulimia nervosa

Physiology and Behavior

Volumn 99, Issue 5, 2010, Pages 611-617

  Bello, Nicholas T ^a   Coughlin, Janelle W ^a   Redgrave, Graham W ^a   Moran, Timothy H ^a   Guarda, Angela S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bulimia; Eating disorders; Hedonics; Insulin; Modified sham feeding; Opiates; Taste

Indexed keywords

GHRELIN; GLUCOSE; KAPPA OPIATE RECEPTOR ANTAGONIST; NALTREXONE; PANCREAS POLYPEPTIDE; PLACEBO;

ADULT; ARTICLE; BLOOD SAMPLING; BULIMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FAT CONTENT; FEAR; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DEPENDENCE; HORMONE RESPONSE; HUMAN; HUNGER; MORNING DOSAGE; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHAM FEEDING; SWALLOWING; TASTE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; AREA UNDER CURVE; BLOOD GLUCOSE; BULIMIA NERVOSA; DIETARY FATS; DOUBLE-BLIND METHOD; FASTING; FEEDING BEHAVIOR; FEMALE; GHRELIN; HUMANS; HUNGER; INSULIN; NALTREXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PEPTIDES; SATIETY RESPONSE; TASTE; YOUNG ADULT;

EID: 77950369096     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.01.033     Document Type: Article

References (47)

1. American Psychiatric Association American Psychiatric Association. Task Force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSM-IV 1994, American Psychiatric Association, Washington, DC, xxvii, 886 pp. 4th ed.
2. Hetherington M.M. Cues to overeat: psychological factors influencing overconsumption. Proc Nutr Soc 2007, 66(1):113-123.
3. Hetherington M.M., Rolls B.J. Dysfunctional eating in the eating disorders. Psychiatr Clin North Am 2001, 24(2):235-248.
4. Kales E.F. Macronutrient analysis of binge eating in bulimia. Physiol Behav 1990, 48(6):837-840.
5. Hetherington M.M., Altemus M., Nelson M.L., Bernat A.S., Gold P.W. Eating behavior in bulimia nervosa: multiple meal analyses. Am J Clin Nutr 1994, 60(6):864-873.
6. Drewnowski A., Bellisle F., Aimez P., Remy B. Taste and bulimia. Physiol Behav 1987, 41(6):621-626.
7. Sunday S.R., Halmi K.A. Taste perceptions and hedonics in eating disorders. Physiol Behav 1990, 48(5):587-594.
8. Mattes R.D. The taste of fat elevates postprandial triacylglycerol. Physiol Behav 2001, 74(3):343-348.
9. Mattes R.D. Fat taste and lipid metabolism in humans. Physiol Behav 2005, 86(5):691-697.
10. De Araujo I.E., Rolls E.T. Representation in the human brain of food texture and oral fat. J Neurosci 2004, 24(12):3086-3093.
11. Yeomans M.R., Gray R.W. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002, 26(6):713-728.
12. Drewnowski A., Krahn D.D., Demitrack M.A., Nairn K., Gosnell B.A. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am J Clin Nutr 1995, 61(6):1206-1212.
13. Fantino M., Hosotte J., Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 1986, 251(1 Pt 2):R91-R96.
14. Bailer U.F., Kaye W.H. A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa. Curr Drug Targets CNS Neurol Disord 2003, 2(1):53-59.
15. Bencherif B., Guarda A.S., Colantuoni C., Ravert H.T., Dannals R.F., Frost J.J. Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior. J Nucl Med 2005, 46(8):1349-1351.
16. Waller D.A., Kiser R.S., Hardy B.W., Fuchs I., Feigenbaum L.P., Uauy R. Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr 1986, 44(1):20-23.
17. Lee M.C., Wagner H.N., Tanada S., Frost J.J., Bice A.N., Dannals R.F. Duration of occupancy of opiate receptors by naltrexone. J Nucl Med 1988, 29(7):1207-1211.
18. Drewnowski A., Shrager E.E., Lipsky C., Stellar E., Greenwood M.R. Sugar and fat: sensory and hedonic evaluation of liquid and solid foods. Physiol Behav 1989, 45(1):177-183.
19. Eiber R., Berlin I., de Brettes B., Foulon C., Guelfi J.D. Hedonic response to sucrose solutions and the fear of weight gain in patients with eating disorders. Psychiatry Res 2002, 113(1-2):173-180.
20. Klein D.A., Schebendach J.E., Brown A.J., Smith G.P., Walsh B.T. Modified sham feeding of sweet solutions in women with and without bulimia nervosa. Physiol Behav 2009, 96(1):44-50.
21. Klein D.A., Schebendach J.S., Devlin M.J., Smith G.P., Walsh B.T. Intake, sweetness and liking during modified sham feeding of sucrose solutions. Physiol Behav 2006, 87(3):602-606.
22. Teff K. Nutritional implications of the cephalic-phase reflexes: endocrine responses. Appetite 2000, 34(2):206-213.
23. Teff K.L., Devine J., Engelman K. Sweet taste: effect on cephalic phase insulin release in men. Physiol Behav 1995, 57(6):1089-1095.
24. Teff K.L., Levin B.E., Engelman K. Oral sensory stimulation in men: effects on insulin, C-peptide, and catecholamines. Am J Physiol 1993, 265(6 Pt 2):R1223-R1230.
25. Crystal S.R., Teff K.L. Tasting fat: cephalic phase hormonal responses and food intake in restrained and unrestrained eaters. Physiol Behav 2006, 89(2):213-220.
26. Monteleone P., Serritella C., Scognamiglio P., Maj M. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa. Psychoneuroendocrinology 2010, 35(2):284-288.
27. Morgan J.F., Reid F., Lacey J.H. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. Bmj 1999, 319(7223):1467-1468.
28. Cotton M.A., Ball C., Robinson P. Four simple questions can help screen for eating disorders. J Gen Intern Med 2003, 18(1):53-56.
29. Mintz L.B., O'Halloran M.S. The Eating Attitudes Test: validation with DSM-IV eating disorder criteria. J Pers Assess 2000, 74(3):489-503.
30. Garner D.M., Olmsted M.P., Bohr Y., Garfinkel P.E. The eating attitudes test: psychometric features and clinical correlates. Psychol Med 1982, 12(4):871-878.
31. Guarda A.S., Coughlin J.W., Cummings M., Marinilli A., Haug N., Boucher M., et al. Chewing and spitting in eating disorders and its relationship to binge eating. Eat Behav 2004, 5(3):231-239.
32. Kovacs D., Mahon J., Palmer R.L. Chewing and spitting out food among eating-disordered patients. Int J Eat Disord 2002, 32(1):112-115.
33. Mauler B.I., Hamm A.O., Weike A.I., Tuschen-Caffier B. Affect regulation and food intake in bulimia nervosa: emotional responding to food cues after deprivation and subsequent eating. J Abnorm Psychol 2006, 115(3):567-579.
34. Kojima S., Ueno N., Asakawa A., Sagiyama K., Naruo T., Mizuno S., et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 2007, 28(2):459-463.
35. Taylor I.L., Impicciatore M., Carter D.C., Walsh J.H. Effect of atropine and vagotomy on pancreatic polypeptide response to a meal in dogs. Am J Physiol 1978, 235(4):E443-E447.
36. Taylor I.L., Feldman M., Richardson C.T., Walsh J.H. Gastric and cephalic stimulation of human pancreatic polypeptide release. Gastroenterology 1978, 75(3):432-437.
37. Casper R.C., Pandy G.N., Jaspan J.B., Rubenstein A.H. Hormone and metabolite plasma levels after oral glucose in bulimia and healthy controls. Biol Psychiatry 1988, 24(6):663-674.
38. Fujimoto S., Inui A., Kiyota N., Seki W., Koide K., Takamiya S., et al. Increased cholecystokinin and pancreatic polypeptide responses to a fat-rich meal in patients with restrictive but not bulimic anorexia nervosa. Biol Psychiatry 1997, 41(10):1068-1070.
39. Moran T.H. Gut peptides in the control of food intake. Int J Obes (Lond) 2009, 33(Suppl 1):S7-S10.
40. Druce M.R., Wren A.M., Park A.J., Milton J.E., Patterson M., Frost G., et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond) 2005, 29(9):1130-1136.
41. Prince A.C., Brooks S.J., Stahl D., Treasure J. Systematic review and meta-analysis of the baseline concentrations and physiologic responses of gut hormones to food in eating disorders. Am J Clin Nutr 2009, 89(3):755-765.
42. Guido M., Romualdi D., Lanzone A. Role of opioid antagonists in the treatment of women with glucoregulation abnormalities. Curr Pharm Des 2006, 12(8):1001-1012.
43. Cucinelli F., Soranna L., Perri C., Barini A., Cento R.M., Mancuso S., et al. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study. Fertil Steril 2004, 81(4):1047-1054.
44. Larsson L.I. Innervation of the pancreas by substance P, enkephalin, vasoactive intestinal polypeptide and gastrin/CCK immunoreactive nerves. J Histochem Cytochem 1979, 27(9):1283-1284.
45. Linari G., Agostini S., Broccardo M., Petrella C., Improta G. Regulation of pancreatic secretion in vitro by nociceptin/orphanin FQ and opioid receptors: a comparative study. Pharmacol Res 2006, 54(5):356-360.
46. McCubbin J.A., Surwit R.S., Kuhn C.M., Cochrane C., Feinglos M.N. Naltrexone potentiates glycemic responses during stress and epinephrine challenge in genetically obese mice. Psychosom Med 1989, 51(4):441-448.
47. Sibilia V., Lattuada N., Rapetti D., Pagani F., Vincenza D., Bulgarelli I., et al. Ghrelin inhibits inflammatory pain in rats: involvement of the opioid system. Neuropharmacology 2006, 51(3):497-505.